79 Percent of US Biotech Firms Contract With Chinese Firms

A new survey finds almost 80 percent of American biotech companies contract with Chinese firms and decoupling from them could be a long game. Some say switching partners could take up to eight years.

China in Focus Weekly Newsletter
Find out what's really going on in China
By registering for the newsletter, you agree to the Privacy Policy.